Accenture Lost 15% Over a Year: One Analyst Says It Will Rise 30% on AI and Digital Transformation
Accenture shed nearly 60% from its peak on fears that AI would gut its consulting revenue, then surged in a single session after earnings. One analyst still sees 30% upside from here, but the broader Wall Street consensus tells a…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Accenture (NYSE:ACN | ACN Price Prediction) currently trades at $212.69. The Street-high price target of $275.00 suggests about 29.3% upside.
Accenture is one of the largest consulting and IT managed services firms globally, posting fiscal 2026 revenue of $74.2 billion. Wall Street viewed it as a test case: does generative AI shrink billable work that IT services firms depend on?
The latest earnings report gave investors a partial answer, and the stock rose 15.99% in a single session. Even after that jump, the gap to the most optimistic target is still large.
AI Cannibalization Fears Cut Accenture in Half Before the Rebound
The selloff came from fear that AI would cannibalize Accenture’s core revenue. Shares fell from a 52-week high of $285.21 to $116.75, a 59% drawdown for a stock with a beta of 1.092.
In the third quarter, new bookings fell 2% in U.S. dollars and 3% in local currency, and revenue came in below estimates for the only time in six quarters ($18.72 billion versus $18.74 billion expected). Federal work wind-down cost about one percentage point of fiscal 2026 growth.
UBS Holds Its $275 Target as Fourth-Quarter Results Back Its Thesis
UBS Group (NYSE:UBS) analyst Kevin McVeigh reiterated a Buy rating with a $275.00 target. His thesis: Accenture is turning AI into revenue at scale, has a large backlog of digital transformation work, and its size allows it win market share as IT spending recovers.
Fourth-quarter results support that view. Revenue of $18.68 billion beat the $18.04 billion consensus. Bookings reached $22.2 billion with a 1.2 book-to-bill ratio, and quarterly client bookings of $100 million or more hit a record 141 for the year. The CEO said, “We continue to believe the opportunities related to AI are greater than the impact of AI-related efficiencies on our business.”
Treat the UBS target with skepticism. Ratings split: 3 Strong Buy, 11 Buy, 13 Hold and zero Sell. The average target of $193.03 is about 9.2% below where the stock trades now, suggesting many analysts have not updated targets since the rally. Fiscal 2027 EPS estimates barely moved at $14.6642 versus $14.6730 90 days ago.
IT Services Sold Off Together, but Accenture Carries the Biggest Bull Case
International Business Machines (NYSE:IBM) is down 22.28% year to date at $225.72. Its average target of $240.59 means 6.6% upside. Ratings stand at 3 Strong Buy, 10 Buy, 10 Hold, 1 Sell and 1 Strong Sell. Barron’s said IBM got a boost from Accenture’s earnings.
Cognizant Technology Solutions (NASDAQ:CTSH) is down 25.39% year to date at $60.88. Its average target of $65.1 means 6.9% upside, with 3 Strong Buy, 10 Buy and 16 Hold ratings.
Wall Street sees single-digit upside for both peers. Only Accenture has a top analyst target pointing toward 30%.
Accenture Still Trails the S&P 500 by Nearly 31 Points This Year
Shares currently sit at $212.69. That is about 29.3% below the UBS target of $275.00 but above the $193.03 consensus. Twenty-eight analysts release fiscal 2027 EPS estimates, and the stock trades at about 15x those estimates.
Year to date, Accenture is down 18.62%, while the S&P 500 is up 12.04%. Over one year, the stock is down 9.8%, compared with a 14.3% gain for the index. Over the past week, the stock rose 19.89%.
I Lean Toward Accenture, but Organic Growth Has to Show Up
The upside argument strengthens if managed services deals close in fiscal 2027 and federal work becomes the “significant contributor” management expects. With an operating margin of 15.9% to 16.1% and $5.5 billion in planned buybacks, EPS can grow even with modest revenue growth.
Pricing declines would strengthen the downside argument if pricing continues slipping. Management reported lower pricing in many areas in the fourth quarter. Acquisitions are expected to add 2 to 2.5% of the 3 to 6% growth guidance, leaving little organic growth. Quarterly free cash flow fell 25.3% year over year.
I lean modestly bullish. The AI cannibalization case looks weaker after this quarter, but most analysts have not raised targets. The $275 target is possible but far from a base case.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
